Influence of PD-L1 gene polymorphism on clinicopathological characteristics and clinical prognosis quality of patients with esophageal cancer

Influence of PD-L1 gene polymorphism on clinicopathological characteristics and clinical prognosis quality of patients with esophageal cancer

Objective: To investigate the effect of programmed death-ligand 1 (PD-L1) gene polymorphism on pathological characteristics and clinical prognosis quality in patients with esophageal cancer. Methods: 86 patients with esophageal cancer treated in our hospital from January 2014 to January 2017 were...

Full description

Bibliographic Details
Main Authors:	Xiao-Ting Wu, Su-Juan Fei
Format:	Article
Language:	English
Published:	Editorial Board of Journal of Hainan Medical University 2021-02-01
Series:	Journal of Hainan Medical University
Subjects:	pd-l1 gene polymorphism esophageal cancer pathological features prognosis
Online Access:	http://www.hnykdxxb.com/PDF/202104/06.pdf

Similar Items

PD-L1 Protein Expression and Gene Amplification Correlate with the Clinicopathological Characteristics and Prognosis of Lung Squamous Cell Carcinoma
by: Chen Z, et al.
Published: (2021-08-01)

PD-L1 expression is an independent predictor of favorable outcome in patients with localized esophageal adenocarcinoma
by: Dagmar Kollmann, et al.
Published: (2018-06-01)

Interactive Effects of PD-L1 Expression in Tumor and Immune Cells on Prognosis of Esophageal Squamous Cell Carcinoma: A One-Center Retrospective Cohort Study
by: Shi F, et al.
Published: (2020-07-01)

Prognostic and Clinicopathological Role of PD-L1 in Endometrial Cancer: A Meta-Analysis
by: Ling Lu, et al.
Published: (2020-04-01)

The clinicopathologic features and prognosis of esophageal neuroendocrine carcinomas: a single-center study of 53 resection cases
by: Lei Ye, et al.
Published: (2019-12-01)

The Clinicopathological Features and Prognosis in Patients With Papillary Renal Cell Carcinoma: A Multicenter Retrospective Study in Chinese Population
by: Baoan Hong, et al.
Published: (2021-09-01)

Prognostic Significance of Serum PD-L1 Level in Patients with Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma Treated with Combination Cytotoxic Chemotherapy
by: Fu R, et al.
Published: (2021-06-01)

Comparative Impact of PD-1 and PD-L1 Inhibitors on Advanced Esophageal or Gastric/Gastroesophageal Junction Cancer Treatment: A Systematic Review and Meta-Analysis
by: SuA Oh, et al.
Published: (2021-08-01)

Low Expression of Programmed Death 1 (PD-1), PD-1 Ligand 1 (PD-L1), and Low CD8+ T Lymphocyte Infiltration Identify a Subgroup of Patients With Gastric and Esophageal Adenocarcinoma With Severe Prognosis
by: Silvio Däster, et al.
Published: (2020-04-01)

The association of XRCC1 polymorphism with osteosarcoma risk, clinicopathologic features, and prognosis in a Chinese Han population
by: Wu YG, et al.
Published: (2018-10-01)

Clinicopathological and prognostic significance of PD-L1 expression in colorectal cancer: a systematic review and meta-analysis
by: Zefeng Shen, et al.
Published: (2019-01-01)

Association of PD-1 polymorphisms with the risk and prognosis of lung adenocarcinoma in the northeastern Chinese Han population
by: Kun Huang, et al.
Published: (2019-11-01)

Association between potentially functional polymorphisms of chemokine family members and the survival of esophageal cancer patients in a Chinese population
by: Du JL, et al.
Published: (2019-06-01)

PD-L1 expression and its clinicopathological correlation in advanced esophageal squamous cell carcinoma in a Chinese population
by: Lulu Rong, et al.
Published: (2019-01-01)

Values of Seven Tumor Markers in Identification and Diagnosis of Esophageal Carcinoma Accompanied by Neuroendocrine Differentiation
by: Lian-ke LIU, et al.
Published: (2015-03-01)

PD-1 Inhibitors in the Advanced Esophageal Cancer
by: Ye Hong, et al.
Published: (2019-11-01)

PD-L1 Expression Promotes Epithelial to Mesenchymal Transition in Human Esophageal Cancer
by: Lujun Chen, et al.
Published: (2017-08-01)

Clinicopathologic characteristics and prognosis of proximal and distal gastric cancer
by: Yu X, et al.
Published: (2018-02-01)

Clinicopathological and prognostic significance of circulating tumor cells in patients with esophageal cancer: a meta-analysis
by: Hou J, et al.
Published: (2018-11-01)

Expression of PD-L1 and PD-1 in Chemoradiotherapy-Naïve Esophageal and Gastric Adenocarcinoma: Relationship With Mismatch Repair Status and Survival
by: Maria C. Svensson, et al.
Published: (2019-03-01)

Prognostic value and clinicopathological characteristics of PD-L1 overexpression in non-Hodgkin lymphoma: a meta-analysis
by: Qiang Zeng, et al.
Published: (2020-01-01)

Intronic polymorphisms in genes LRFN2 (rs2494938) and DNAH11 (rs2285947) are prognostic indicators of esophageal squamous cell carcinoma
by: Jiru Wang, et al.
Published: (2019-05-01)

Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma
by: Wei Guo, et al.
Published: (2021-05-01)

miR‐493 by regulating of c‐Jun targets Wnt5a/PD‐L1‐inducing esophageal cancer cell development
by: Wei Bian, et al.
Published: (2021-05-01)

Prognostic role of PD-L1 for HCC patients after potentially curative resection: a meta-analysis
by: Gao-Min Liu, et al.
Published: (2019-01-01)

Effects of EFNA1 on cell phenotype and prognosis of esophageal carcinoma
by: Yongqiang Zhang, et al.
Published: (2021-08-01)

Correlation between MDM2 T309G single nucleotide polymorphism and esophageal cancer susceptibility: An updated meta‐analysis
by: Lele Yin, et al.
Published: (2020-03-01)

The efficacy and safety of antibodies targeting PD-1 for treatment in advanced esophageal cancer: A systematic review and meta-analysis
by: Yao Lu, et al.
Published: (2021-06-01)

Phenotypic profiling and prognostic significance of immune infiltrates in esophageal squamous cell carcinoma
by: Chuqing Pan, et al.
Published: (2021-01-01)

Comprehensive Analysis and Identification of Key Driver Genes for Distinguishing Between Esophageal Adenocarcinoma and Squamous Cell Carcinoma
by: Feng Wang, et al.
Published: (2021-05-01)

High serum PD‐L1 level is a poor prognostic biomarker in surgically treated esophageal cancer
by: Masaaki Ito, et al.
Published: (2020-02-01)

Prognostic and Clinicopathological Significance of PD-L1 Expression for Colorectal Cancer: A Meta-analysis
by: RAO Xionghui, et al.
Published: (2019-11-01)

Correlation Study of the Long-Term Prognosis of Venous Thromboembolism and Inflammatory Gene Polymorphisms
by: Abuduhalike R, et al.
Published: (2020-12-01)

Sex-Based Heterogeneity in the Clinicopathological Characteristics and Prognosis of Breast Cancer: A Population-Based Analysis
by: Yiqun Han, et al.
Published: (2021-02-01)

Over-expression of Nectin-4 promotes progression of esophageal cancer and correlates with poor prognosis of the patients
by: Haifeng Deng, et al.
Published: (2019-04-01)

Prognostic and clinicopathological value of PD-L1 in colorectal cancer: a systematic review and meta-analysis
by: Yang L, et al.
Published: (2019-05-01)

Identification of miRNAs as prognostic factors for esophageal squamous cell carcinoma
by: Meng Chen, et al.
Published: (2020-01-01)

Single nucleotide polymorphisms in CRTC1 and BARX1 are associated with esophageal adenocarcinoma
by: Anna M. J. van Nistelrooij, et al.
Published: (2015-01-01)

PIM1 polymorphism and PIM1 expression as predisposing factors of esophageal squamous cell carcinoma in the Asian population
by: Wu YB, et al.
Published: (2016-05-01)

Association Between Multiple Lines of Active Therapy and Prognosis in Esophageal Squamous Cell Carcinoma
by: Yang Y, et al.
Published: (2020-03-01)

Cannot write session to /tmp/vufind_sessions/sess_o7egnm1iet6ssgvg17ro8ec4ca